Sign In

SmartKem secures €3 million from investors including BASF

13 August 2014 15:54
By Tornado Staff

SmartKem, a UK provider of organic semiconductor inks to enable printing of thin film transistors, has received a round of funding from BASF Venture Capital, Octopus Investments and Entrepreneurs Fund.

SmartKem’s high-performance organic semiconductor inks are used in printed thin film transistors (TFTs). These drive unbreakable and flexible electronics, such as flexible OLED (Organic Light Emitting Diodes) displays. TFTs have the function to switch pixels on and off. Current display technologies based on inorganic TFT materials (eg silicon or metal oxide systems) are processed on glass at high temperatures. When it comes to true flexibility, conventional TFT systems reach their boundaries. Organic thin film transistors are inherently more flexible. They can be processed on plastic films as they are printable at low temperatures.

Steve Kelly, CEO of SmartKem, stated: “We are happy to join forces in research and development with BASF to progress smart chemistry for the new generation of flexible displays and circuits.”

SmartKem has a pipeline of inks that are under evaluation by various partners in the industry. Its business model is focused on delivering expertise in molecular design, synthesis, application engineering and technology transfer to customers.

Related stories
Bitcoin tech company KnCMiner gets $15 million in Series B round
€8.2 million financing round and new CEO for DelfMEMS
GLO appoints former Philips Lighting exec as chairman
€9.5 million first round for Energy Micro
Virtensys appoints John Nicholson as chairman


Tech investments
From our Online Data Service
VC-backed companies
From our Radar

Recent Deals

Oct 4€16.0MBiopharmaceuticals
Oct 4€1.0MInternet commerce
Oct 4N/ADigital signal processing
Oct 2N/AInternet commerce
Oct 1N/AInternet services
Oct 1N/AMedical devices
Oct 1€12.5MWireless applications

For information on Europe's most extensive database on technology funding click here!


BIO-Europe 2015
November 2 - 4, 2015

November 10 - 11, 2015

Press Releases

Oct 6
versasec triples government security business

Sep 30
BioRegio STERN Management
tübingen-based start-up atriva therapeutics gmbh develops innovativ...

Sep 29
Magic Event
with 1.5 million euros in hand, is looking to attrac...

Sep 29
swarm64 as raises up to eur7.1m from alliance venture, target partn...

Sep 29
Cristal Therapeutics (formerly Cristal Delivery)
cristal therapeutics starts clinical phase i trial with nanomedicin...

About usContact usLegal Information
Copyright © 1999-2015
Emerging Technology Research Europe Inc. All rights reserved.